Presentation is loading. Please wait.

Presentation is loading. Please wait.

Left atrial appendage exclusion: An alternative to anticoagulation in nonvalvular atrial fibrillation  Kareem Bedeir, MBChB, MS, David R. Holmes, MD,

Similar presentations


Presentation on theme: "Left atrial appendage exclusion: An alternative to anticoagulation in nonvalvular atrial fibrillation  Kareem Bedeir, MBChB, MS, David R. Holmes, MD,"— Presentation transcript:

1 Left atrial appendage exclusion: An alternative to anticoagulation in nonvalvular atrial fibrillation  Kareem Bedeir, MBChB, MS, David R. Holmes, MD, James L. Cox, MD, Basel Ramlawi, MD, MSc  The Journal of Thoracic and Cardiovascular Surgery  Volume 153, Issue 5, Pages (May 2017) DOI: /j.jtcvs Copyright © 2017 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Endocardial left atrial appendage occluding devices. A, The PLAATO device. B, The Watchman. C, The Amplatzer cardiac plug. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2017 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 Epicardial left atrial appendage occluding devices. A, The Lariat suture delivery system. B, The Cardioblate occlusion device. *Currently not approved by the Food and Drug Administration. C, The TigerPaw system II. D, The Atriclip exclusion system (standard open approach). E, The Atriclip exclusion system (thoracoscopic approach). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2017 The American Association for Thoracic Surgery Terms and Conditions

4 Figure 3 Proposed approach to stroke risk reduction in patients with atrial fibrillation not undergoing open cardiac procedures. *Preferred, with contraindications to anticoagulation or unfavorable left atrial appendage morphology. **Preferred with nonsurgical candidates and those with previous cardiac or left thoracic surgery. CHA2DS2-VASc, congestive heart failure, hypertension, age >75 and diabetes mellitus, previous history of stroke or transient ischemic attack, vascular disease, age 65-74 years, and female sex category; AC, anticoagulation, TTR, time in therapeutic range, LAA, left atrial appendage; LAAE, left atrial appendage exclusion. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2017 The American Association for Thoracic Surgery Terms and Conditions

5 Figure 4 The Watchman endocardial left atrial occlusion device (left) and the AtriClip epicardial left atrial occlusion device (right). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2017 The American Association for Thoracic Surgery Terms and Conditions

6 The Watchman endocardial left atrial occlusion device (left) and the AtriClip epicardial left atrial occlusion device (right). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2017 The American Association for Thoracic Surgery Terms and Conditions


Download ppt "Left atrial appendage exclusion: An alternative to anticoagulation in nonvalvular atrial fibrillation  Kareem Bedeir, MBChB, MS, David R. Holmes, MD,"

Similar presentations


Ads by Google